{
  "resourceType": "EvidenceVariable",
  "id": "example-alteplase-for-stroke",
  "text": {
    "status": "generated",
    "div": "\u003cdiv xmlns\u003d\"http://www.w3.org/1999/xhtml\"\u003e\n      \n      \u003cp\u003e\n        \u0026quot;Alteplase for Stroke\u0026quot; is an exposure concept with a detailed dosing instruction that may be used in expressing what an Evidence is about.\n      \u003c/p\u003e\n\t\n    \u003c/div\u003e"
  },
  "contained": [
    {
      "resourceType": "Group",
      "id": "Definition-Group",
      "title": "VariableDefinition: Alteplase for Stroke",
      "membership": "conceptual",
      "characteristic": [
        {
          "code": {
            "text": "Defined by Reference"
          },
          "valueUri": "http://example.org/fhir/ActivityDefinition/example-alteplase-dosing",
          "exclude": false,
          "description": "IV alteplase 0.9 mg/kg (maximum 90 mg) as 10% of dose over 1 minute and 90% over 1 hour"
        }
      ]
    }
  ],
  "extension": [
    {
      "url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-wg",
      "valueCode": "cds"
    }
  ],
  "name": "AlteplaseForStroke",
  "title": "Alteplase for Stroke",
  "status": "draft",
  "publisher": "HL7 International / Clinical Decision Support",
  "contact": [
    {
      "telecom": [
        {
          "system": "url",
          "value": "http://www.hl7.org/Special/committees/dss"
        }
      ]
    }
  ],
  "description": "Alteplase for Stroke",
  "actual": false,
  "definition": {
    "reference": {
      "reference": "#Definition-Group"
    }
  },
  "meta": {
    "tag": [
      {
        "system": "http://terminology.hl7.org/CodeSystem/v3-ActReason",
        "code": "HTEST",
        "display": "test health data"
      }
    ]
  }
}